Peter Goldschmidt
|
|
|
Peter Goldschmidt, M.D., PH.d., DMS is founder and president of Health Improvement Institute, a non-profit organization dedicated to improving the quality and productivity of America's health care. The Institute is best known for its awards programs, including the annual Aesculapius Awards honoring excellence in health-oriented Web sites and television and radio public service announcements.
Dr. Goldschmidt is also chief executive officer of MCMC LLC, the largest multi-line provider of independent medical reviews and related services to inform health care decision-making and to improve the quality of care. He was formerly Director of the Health Services Research and Development Service, U.S. Department of Veterans Affairs (VA), Washington, DC.
Dr. Goldschmidt has a long-standing interest in the quality of health information and in enabling people to become educated consumers. He has extensive experience in the design and deployment of health and management information systems and decision support technologies (expert systems). He is an expert on outcomes research and cost-effectiveness analysis, and the author of the comprehensive manual Quality management in heath care (published by McGraw Hill, 1995). For the U.S. Department of Defense, he designed the worldwide Civilian External Peer review Program. He also designed QSM, the first commercially available system for routinely assessing the quality of hospital care.
As a consultant to the U.S. Institute of Medicine, he designed the Medical Technology Assessment Directory. He is a former member of the U.S. Technology Coordinating Committee. His activities for the U.S. Congress Office of Technology Assessment included writing a background paper for its study on the quality of medical care and serving on the advisory panel for its study of VA Decentralized Hospital Computer Systems. His most important studies include the Medical Practice Information Demonstration Project for the U.S. Department of Health and Human Services, and a Comprehensive Study of the Ethical, Legal, and Social Implications of Biomedical and Behavioral Research and Technology, a study mandated by the U.S. Congress.
Dr. Goldschmidt's international health experience includes missions for the U.S. Trade and Development Agency (US-TDA), U.S. Agency for International Development (US-AID), World Bank, and World Health Organization (WHO).
Dr. Goldschmidt is a graduate of University College Hospital Medical School in London, the University of Westminster School of Management Studies in London, and The Johns Hopkins University School of Hygiene and Public Health. |
